Live
Home·Deals·Pharmaceutical·Sun Pharma acquires Organon
Sun Pharma acquires Organon (2026)
SEO URLwww.firestrike.ai/deals/organon-sun-pharma-acquisition-2026-9
acquisitionAnnounced · Jan 20, 2026PharmaceuticalSource · Unverified ReportsArticle · Expectations
Organon
Sun Pharma
Organon · Sun Pharma

Sun Pharma acquires Organon

David Najork
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
ShareXLinkedInEmail
Deal value
$10B
Target
Organon
Organon
NYSE: OGN · Jersey City, New Jersey
Acquirer
Sun Pharma
Sun Pharma
Full Acquisition
Status
Speculative

Sun Pharma agreed to acquire Organon. Reported deal value: $10B. Status: Speculative. Sector: Pharmaceutical. Target headquarters context: Jersey City, New Jersey, United States.

This page summarizes publicly available information about the transaction as of 2026-01-20. Figures and status may change as filings and press coverage update.

Sun Pharmaceutical Evaluates Organon Acquisition to Scale US Business Sun Pharmaceutical Evaluates Organon Acquisition to Scale US Business By - January 20, 2026 Sun Pharmaceutical Industries , India largest drugmaker by market capitalisation and revenue, is reportedly evaluating the acquisition of US-based Organon , a company focused on women health with a rapidly expanding presence in the biosimilars market

Deal timeline

Announced
Jan 20, 2026 · chemindigest.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context

This transaction is classified in Pharmaceutical with a reported deal value of $10B. Figures and status may change as sources update.

Sources: chemindigest.com · Primary article · FireStrike proprietary index